Silent clues in blood: Proteomic approach for Alzheimer's disease.
Current research focused on blood protein biomarkers may reveal key clues for fully understanding the etiology of AD, enabling earlier diagnosis and monitoring of its progression, thereby paving the way for research targeting a cure.